+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Immunotherapy"

Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities - Product Thumbnail Image

Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities

  • Report
  • May 2022
  • 32 Pages
  • Global
From
Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective - Product Thumbnail Image

Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective

  • Report
  • October 2021
  • 433 Pages
  • Global
From
Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028

  • Report
  • December 2023
  • 220 Pages
  • Global
From
Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028 - Product Thumbnail Image

Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028

  • Report
  • June 2022
  • 1500 Pages
  • Global
From
Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2028 - Product Thumbnail Image

Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2028

  • Drug Pipelines
  • May 2022
  • 400 Pages
  • Global
From
Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025 - Product Thumbnail Image

Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025

  • Report
  • February 2021
  • 100 Pages
  • Global
From
Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppression, That is the Question - Product Thumbnail Image

Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppression, That is the Question

  • Report
  • May 2019
  • 17 Pages
  • Global
From
PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032

  • Report
  • September 2022
  • 247 Pages
  • Global
From
Global Intratumoral Cancer Therapy Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis - Product Thumbnail Image

Global Intratumoral Cancer Therapy Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis

  • Report
  • February 2022
  • 172 Pages
  • Global
From
Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026

  • Report
  • October 2021
  • 210 Pages
  • Global
From
Cancer Immunotherapy Market Size, Share & Trends Analysis Report, Product, Application, Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End Use, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Cancer Immunotherapy Market Size, Share & Trends Analysis Report, Product, Application, Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End Use, Region, and Segment Forecasts, 2024-2030

  • Report
  • December 2023
  • 110 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal antibodies, Immunomodulators), By Cancer Type (Lung, Breast), By Service Type, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal antibodies, Immunomodulators), By Cancer Type (Lung, Breast), By Service Type, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 98 Pages
  • Global
From
Bispecific Antibody Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report By Indication (Cancer, CNS Conditions), By Route of Administration, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report By Indication (Cancer, CNS Conditions), By Route of Administration, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • August 2023
  • 175 Pages
  • Global
From
Immune Checkpoint Inhibitors Market Size, Share & Trends Analysis Report by Type (PD-1, PD-L1, CTLA-4), Application (Lung Cancer, Breast Cancer, Melanoma), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market Size, Share & Trends Analysis Report by Type (PD-1, PD-L1, CTLA-4), Application (Lung Cancer, Breast Cancer, Melanoma), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • May 2024
  • 150 Pages
  • Global
From
Liver Metastases Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy), Primary Cancer, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Liver Metastases Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy), Primary Cancer, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • January 2024
  • 100 Pages
  • Global
From
Sarcoma Drugs Market Size, Share & Trends Analysis Report By Treatment Type (Chemotherapy, Targeted Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Sarcoma Drugs Market Size, Share & Trends Analysis Report By Treatment Type (Chemotherapy, Targeted Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 93 Pages
  • Global
From
Innovation Waves in Immuno-oncology Therapy Development - Product Thumbnail Image

Innovation Waves in Immuno-oncology Therapy Development

  • Report
  • February 2024
  • 75 Pages
  • Global
From
Targeted Immunotherapy in Oncology - Product Thumbnail Image

Targeted Immunotherapy in Oncology

  • Report
  • November 2021
  • 106 Pages
  • Global
From
Investigation Report on China's Pembrolizumab Market, 2021-2025 - Product Thumbnail Image

Investigation Report on China's Pembrolizumab Market, 2021-2025

  • Report
  • April 2021
  • China
From
Cancer Immunotherapy Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Cancer Immunotherapy Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Loading Indicator

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer. Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more